Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles

Immunity

Volumn 7, Issue 1, 1997, Pages 97-112

  Doolan, Denise L ^a   Hoffman, Stephen L ^a   Southwood, Scott ^b   Wentworth, Peggy A ^b   Sidney, John ^b   Chesnut, Robert W ^b   Keogh, Elissa ^b   Appella, Ettore ^g   Nutman, Thomas B ^c   Lal, Altaf ^d   Gordon, Daniel M ^e   Oloo, Aggrey ^f   Sette, Alessandro ^b  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b CYTEL CORPORATION   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; HLA ANTIGEN CLASS 1; TUMOR NECROSIS FACTOR ALPHA;

ALLELISM; ANTIGENIC VARIATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOLECULAR RECOGNITION; PEPTIDE ANALYSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0030747677     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80513-0     Document Type: Article

References (59)

1. Aidoo, M., Lalvani, A., Allsopp, C.E.M., Plebanski, M., Meisner, S.J., Krausa, P., Browning, M., Morris-Jones, S., McAdam, S., Gotch, F., et al. (1995). Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345, 1003-1007.
2. Beadle, C., McElroy, P.D., Oster, C.N., Beier, J.C., Oloo, A.J., Onyango, F.K., Chumo, O.K., Bales, J.D., Sherwood, J.A., and Hoffman, S.L. (1995). Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine design. J. Infect. Dis. 172, 1047-1054.
3. Beier, J.C., Oster, C.N., Onyango, F.K., Bales, J.D., Sherwood, J.A., Perkins, P.V., Chumo, O.K., Koech, D.V., Whitmire, R.E., Roberts, C.R., et al. (1994). Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J. Trop. Med. Hyg. 50, 529-536.
4. Buus, S., Sette, A., Colon, S., Miles, S., and Grey, H.M. (1987). The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic peptides. Science 235, 1353-1358.
5. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P.A., Chesnut, R.W., Grey, H.M., Sette, A., and Serra, H.M. (1994). Induction of antitumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91, 2105-2109.
6. Chicz, R.M., and Urban, R.G. (1994). Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development, Immunol. Today 15, 155-160.
7. del Guercio, M.-F., Sidney, J., Hermanson, G., Perez, C., Grey, H.M., Kubo, R.T., and Sette, A. (1995). Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154, 685-693.
8. Doolan, D.L., Houghten, R.A., and Good, M.F. (1991). Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Int. Immunol. 3, 511-516.
9. Doolan, D.L., Saul, A.J., and Good, M.F. (1992). Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Infect. Immun. 60, 675-682.
10. Doolan, D.L., Khamboonruang, C., Beck, H.P., Houghten, R.A., and Good, M.F. (1993). Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. Int. Immunol. 5, 37-46.
11. + T cell, interferon-γ, and nitric oxide dependent immunity. J. Exp. Med. 183, 1739-1746.
12. Doolan, D.L., Wizel, B., and Hoffman, S.L. (1996b). Class I restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs. Immunol. Res. 15, 280-305.
13. Doolan, D.L., and Hoffman, S.L. (1997). Multi-gene vaccination against malaria: a multi-stage, multi-immune response approach. Parasitol. Today 13, 171-178.
14. Egan, J.E., Hoffman, S.L., Haynes, J.D., Sadoff, J.C., Schneider, I., Grau, G.E., Hollingdale, M.R., Ballou, W.R., and Gordon, D.M. (1993). Humoral immune response in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 49, 166-173.
15. Ferreira, A., Schofield, L., Enea, V., Schellekens, H., van der Meide, P., Collins, W.E., Nussenzweig, R.S., and Nussenzweig, V. (1986). Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 232, 881-884.
16. Franco, A., Appella, E., Kagnoff, M.F., Chowers, Y., Sakaguchi, K., Grey, H.M., and Sette, A. (1994). Peripheral T cell response to A-gliadin in celiac disease: differential processing and presentation capacities of Epstein-Barr-transformed B cells and fibroblasts. Clin. Immunol. Immunopathol. 71, 75-81.
17. Hill, A.V.S., Allsopp, C.E.M., Kwiatkowki, D., Anstey, N.M., Twumasi, P., Rowe, P.A., Bennett, S., Brewster, D., McMichael, A., and Greenwood, B.M. (1991). Common West African HLA antigens are associated with protection from severe malaria. Nature 352, 595-600.
18. Hill, A.V.S., Elvin, J., Willis, A.C., Aidoo, M., Allsopp, C.E., Gotch, F.M., Gao, X.M., Takiguchi, M., Greenwood, B.M., Townsend, A.R., et al. (1992). Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434-439.
19. Hoffman, S.L., Isenbarger, D., Long, G.W., Sedegah, M., Szarfman, A., Waters, L., Hollingdale, M.R., van der Miede, P.H., Finbloom, D.S., and Ballou, W.R. (1989). Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244, 1078-1081.
20. Hoffman, S.L., Weiss, W., Mellouk, S., and Sedegah, M. (1990). Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes. Immunol. Lett. 25, 33-38.
21. Hoffman, S.L., Franke, E.D., Hollingdale, M.R., and Druilhe, P. (1996). Attacking the infected hepatocyte. In Malaria Vaccine Development, S.L. Hoffman, ed. (Washington, DC: ASM Press), pp. 35-76.
22. + cytotoxic T cell clone recognizing sporozoite surface protein 2. Infect. Immun. 62, 2979-2983.
23. Kubo, R.T., Sette, A., Grey, H.M., Appella, E., Sakaguchi, K., Zhu, N. Z., Arnott, D., Sherman, N., Shabanowitz, J., Michel, H., et al. (1994). Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152, 3913-3924.
24. Lalvani, A., Hurt, N., Aidoo, M., Kibatala, P., Tanner, M., and Hill, A.V.S. (1996). Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur. J. Immunol. 26, 773-779.
25. Malik, A., Egan, J.E., Houghton, R.A., Sadoff, J.C., and Hoffman, S. L. (1991). Human cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. Proc. Natl. Acad. Sci. USA. 88, 3300-3304.
26. McCutchan, T.F., and Waters, A.P. (1990). Mutations with multiple independent origins in surface antigens mark the targets of biological selective pressure. Immunol. Lett. 25, 23-26.
27. McElroy, P.D., Beier, J.C., Oster, C.N., Beadle, C., Sherwood, J.A., Oloo, A.J., and Hoffman, S.L. (1994). Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Am. J. Trop. Med. Hyg. 51, 523-532.
28. Mellouk, S., Maheshwari, R.K., Rhodes-Feuillette, A., Beaudoin, R.L., Berbiguier, N., Matile, H., Miltgen, F., Landau, I., Pied, S., Chigot, J. P.,et al. (1987). Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J. Immunol. 139, 4192-4195.
29. Mellouk, S., Green, S.J., Nacy, C.A., and Hoffman, S.L. (1991). IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 146, 3971-3976.
30. Nussler, A., Pied, S., Goma, J., Renia, L., Miltgen, F., Grau, G.E., and Mazier, D. (1991). TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6. Int. Immunol. 3, 317-321.
31. Ooba, T., Hayashi, H., Karaki, S., Tanabe, M., Kano, K., and Takiguchi, M. (1989). The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 30, 76-80.
32. Ponnudurai, T., Leeuenberg, A.D., and Meuwissen, J.H. (1981). Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Trop. Geogr. Med. 33, 50-54.
33. Rajadhyaksha, M., and Thanavala, Y. (1995). Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide. Proc. Natl. Acad. Sci. USA 92, 1575-1579.
34. Rebai, N., and Malissen, B. (1983). Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens 22, 107-117.
35. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3, 579-585.
36. Romero, P., Maryanski, J.L., Corradin, G., Nussenzweig, R.S., Nussenzweig, V., and Zavala, F. (1989). Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341, 323-325.
37. Ruppert, J., Sidney, J., Celis, E., Kubo, R.T., Grey, H.M., and Sette, A. (1993). Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74, 929-937.
38. Schofield, L., Ferreira, A., Nussenzweig, V., and Nussenzweig, R.S. (1987a). Antimalarial activity of alpha tumor necrosis factor and gamma-interferon. Fed. Proc. 46, 760.
39. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664-666.
40. + cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J. Immunol. 149, 966-971.
41. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W.M., Melief, C.J.M., Oseroff, C., Yuan, L., Ruppert, J., et al. (1994). The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153, 5586-5592.
42. Shimizu, Y., and DeMars, R. (1989). Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J. Immunol. 142, 3320-3328.
43. Sidney, J., del Guercio, M.-F., Southwood, S., Engelhard, V.H., Appella, E., Rammwnsee, H., Falk, K., Rotzschke, O., Takiguchi, M., Kubo, R.T., et al. (1995). Several HLA alleles share overlapping peptide specificities. J. Immunol. 154, 247-259.
44. Sidney, J., Grey, H.M., Kubo, R.T., and Sette, A. (1996a). Practical, biochemical and evolutionary implications of the discovery of HLA class I supertypes. Immunol. Today 17, 261-266.
45. Sidney, J., Grey, H.M., Southwood, S., Celis, E., Wentworth, P.A., del Guercio, M.-F., Kubo, R.T., Chesnut, R.W., and Sette, A. (1996b). Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide binding repertoires of common HLA molecules. Hum. Immunol. 45, 79-93.
46. Sidney, J., Southwood, S., del Guercio, M.-F., Grey, H.M., Chesnut, R. W., Kubo, R.T., and Sette, A. (1996c). Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J. Immunol. 157, 3480-3490.
47. Steel, C., Lujan-Trangay, A., Gonzalez-Peralta, C., Zea-Flores, G., and Nutman, T.B. (1984). Transient changes in cytokine profiles following Ivermectin treatment of Onchocerciasis. J. infect. Dis. 170, 962-970.
48. Storkus, W.J., Zeh, H.J.I., Maeurer, M.J., Salter, R.D., and Lotze, M.T. (1993). Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J. Immunol. 151, 3719-3727.
49. Suhrbier, A., Rodda, S.J., Ho, P.C., Csurhes, P., Dunckley, H., Saul, A., Geysen, H.M., and Rzepczyk, C.M. (1991). Role of single amino acids in the recognition of a T cell epitope. J. Immunol. 147, 2507-2513.
50. van der Most, R.G., Sette, A., Oseroff, C., Alexander, J., Murali-Krishna, K., Lau, L.L., Southwood, S., Sidney, J., Chesnut, R. W., Matloubian, M., et al. (1996). Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic Lymphocytic Choriomeningitis virus infection. J. Immunol. 157, 5543-5554.
51. van Endert, P.M., Riganelli, D., Greco, G., Fleischhauer, K., Sidney, J., Sette, A., and Bach, J.F. (1995). The peptide-binding motif for the human transporter associated with antigen processing. J. Exp. Med. 182, 1883-1895.
52. Vitiello, A., Ishioka, G., Grey, H., Rose, R., Farness, P., LaFond, R., Yuan, L., Chisari, F., Furze, J., Bartholomeuz, R., and Chesnut, R. (1995). Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection: induction of a primary cytotoxic T lymphocyte response in man. J. Clin. Invest. 95, 341-349.
53. Walliker, D., Quakyi, I.A., Wellems, T.E., McCutchan, T.F., Szarfman, A., London, W.T., Corcoran, L.M., Burkot, T.R., and Carter, R. (1987). Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236, 1661-1666.
54. Weiss, W.R., Mellouk, S., Houghten, R.A., Sedegah, M., Kumar, S., Good, M.F., Berzofsky, J.A., Miller, L.H., and Hoffman, S.L. (1990). Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171, 763-773.
55. Weiss, W.R., Berzovsky, J.A., Houghten, R., Sedegah, M., Hollingdale, M., and Hoffman, S.L. (1992). A T cell clone directed at the circumsporozoite protein which protects mice against both P. yoelii and P. berghei. J. Immunol. 149, 2103-2109.
56. Wentworth, P.A., Vitiello, A., Sidney, J., Keogh, E., Chesnut, R.W., Grey, H.M., and Sette, A. (1996). Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. Eur. J. Immunol. 26, 97-101.
57. Wizel, B., Houghten, R., Church, P., Tine, J.A., Lanar, D.E., Gordon, D. M., Ballou, W.R., Sette, A., and Hoffman, S.L. (1995a). HLA-A2 restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155, 766-775.
58. Wizel, B., Houghten, R.A., Parker, K.C., Coligan, J.E., Church, P., Gordon, D.M., Ballou, W.R., and Hoffman, S.L. (1995b). Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. J. Exp. Med. 182, 1435-1445.
59. World Health Organization (1994). World malaria situation in 1992. Wkly. Epidemiol. Rec. 69, 309-314.